Enzo Biochem Valuation
| ENZ Stock | USD 1.06 0.03 2.75% |
Today, the firm appears to be undervalued. Enzo Biochem shows a prevailing Real Value of $2.14 per share. The current price of the firm is $1.06. Our model computes the value of Enzo Biochem from reviewing the firm fundamentals such as Profit Margin of 0.99 %, current valuation of 2.78 M, and Shares Outstanding of 51.23 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Enzo Biochem's valuation include:
Price Book 0.8468 | Enterprise Value 2.8 M | Enterprise Value Ebitda (0.42) | Price Sales 1.8271 | Enterprise Value Revenue 0.2096 |
Undervalued
Today
Please note that Enzo Biochem's price fluctuation is relatively risky at this time. Calculation of the real value of Enzo Biochem is based on 3 months time horizon. Increasing Enzo Biochem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Enzo Biochem is useful when determining the fair value of the Enzo stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Enzo Biochem. Since Enzo Biochem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enzo Stock. However, Enzo Biochem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.06 | Real 2.14 | Target 5.5 | Hype 1.06 | Naive 0.98 |
The real value of Enzo Stock, also known as its intrinsic value, is the underlying worth of Enzo Biochem Company, which is reflected in its stock price. It is based on Enzo Biochem's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Enzo Biochem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enzo Biochem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enzo Biochem helps investors to forecast how Enzo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enzo Biochem more accurately as focusing exclusively on Enzo Biochem's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Enzo Biochem's intrinsic value based on its ongoing forecasts of Enzo Biochem's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Enzo Biochem's closest peers. When choosing an evaluation method for Enzo Biochem, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Enzo Biochem Investments |
|
Enzo Valuation Trend
Knowing Enzo Biochem's actual value is paramount for traders to make sound investment determinations. Enzo Biochem's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Enzo Biochem's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Enzo Biochem's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Enzo Market Cap
Enzo Biochem is rated # 4 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 3.25 Billion. Enzo Biochem claims roughly 55.84 Million in market capitalization contributing just under 2% to equities under Health Care industry.Enzo Biochem Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Enzo Biochem's current stock value. Our valuation model uses many indicators to compare Enzo Biochem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enzo Biochem competition to find correlations between indicators driving Enzo Biochem's intrinsic value. More Info.Enzo Biochem is one of the top stocks in price to earning category among related companies. It is rated # 3 in price to book category among related companies fabricating about 0.03 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Enzo Biochem is roughly 31.41 . Price To Book Ratio is likely to drop to 1.01 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzo Biochem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzo Biochem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enzo Biochem's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Enzo Biochem's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Enzo Biochem and how it compares across the competition.
About Enzo Biochem Valuation
The stock valuation mechanism determines the current worth of Enzo Biochem on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Enzo Biochem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Enzo Biochem based exclusively on its fundamental and basic technical indicators. By analyzing Enzo Biochem's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Enzo Biochem's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enzo Biochem. We calculate exposure to Enzo Biochem's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enzo Biochem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 13.3 M | 12.6 M | |
| Pretax Profit Margin | (0.93) | (0.88) | |
| Operating Profit Margin | (0.72) | (0.68) | |
| Net Profit Margin | 0.75 | 0.79 | |
| Gross Profit Margin | 0.43 | 0.61 |
8 Steps to conduct Enzo Biochem's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Enzo Biochem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Enzo Biochem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Enzo Biochem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Enzo Biochem's revenue streams: Identify Enzo Biochem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Enzo Biochem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Enzo Biochem's growth potential: Evaluate Enzo Biochem's management, business model, and growth potential.
- Determine Enzo Biochem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Enzo Biochem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Enzo Biochem Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Enzo Biochem does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 49.2 M |
Enzo Biochem Current Valuation Indicators
Valuation refers to the process of determining the present value of Enzo Biochem and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Enzo we look at many different elements of the entity such as Enzo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Enzo Biochem's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Enzo Biochem's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Enzo Biochem, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Enzo Biochem's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Enzo Biochem's worth.When determining whether Enzo Biochem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enzo Biochem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enzo Biochem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enzo Biochem Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Enzo Stock analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.657 | Quarterly Revenue Growth 0.138 | Return On Assets (0.17) | Return On Equity (0.45) |
The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.